Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 8 hours ago
Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
about 8 hours ago
Just a few months after ripping up the central nervous system-focused portion...
Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
about 12 hours ago
Amid industry layoffs and M&A headlines, Big Pharma's embrace of AI is...
AACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’
about 13 hours ago
NCI Director Letai envisions a return to normalcy for cancer research funding...
AcuityMD raises $80M to help bolster AI in the medtech industry
about 13 hours ago
AcuityMD has raised $80 million—with a company valuation now nearing $1 billion—to...
McKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B
about 14 hours ago
McKesson has let go of a minority share of its medical/surgical solutions...
Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial
about 19 hours ago
A little over a year after reabsorbing its anticoagulant abelacimab, Novartis has...
Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials
1 day ago
Roche has shared details of fatalities in its phase 3 relapsing multiple...
Racing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset
1 day ago
Kyverna Therapeutics has unveiled the full results from its registrational trial of...
AACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises
1 day ago
After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib...
Pulnovo Medical scores $100M in finance round led by Medtronic
1 day ago
Pulnovo Medical, a Chinese medtech focused on therapies that target pulmonary hypertension...
Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
1 day ago
Pfizer's chief strategy and innovation officer Andrew Baum is stepping down merely...
Tortugas comes out of its shell with $106M to fund 4 phase 2-stage neuro drugs licensed from Asia
1 day ago
A pair of Sage veterans have launched a neurology-focused startup armed with...